MedPath

Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes

Not Applicable
Active, not recruiting
Conditions
Type 2 Diabetes Mellitus
Interventions
Other: Aerobic Exercise Training
Registration Number
NCT01176578
Lead Sponsor
Baltimore VA Medical Center
Brief Summary

The discovery of the role of endothelial progenitor cells (EPCs) and their involvement in the cardiovascular complications of type 2 diabetes (T2DM) would quickly have a significant impact on the millions of Americans who have T2DM. This project is designed to 1) determine the mechanisms underlying EPC dysfunction in older, sedentary adults with T2DM compared those with normal glucose metabolism and impaired glucose metabolism, and 2) determine if aerobic exercise training is an efficacious therapy for EPC dysfunction in T2DM, and whether improvement in EPC number and function translates to improved endothelial function, increased capillarization, and improved glucose metabolism in T2DM.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Age 50-80
  • Non-smoker
  • If woman, postmenopausal >1 year
Exclusion Criteria
  • History of heart disease or stroke
  • Cancer
  • Poorly controlled hypertension or dyslipidemia
  • Kidney or Liver diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IGTAerobic Exercise TrainingImpaired Glucose Tolerance
NGTAerobic Exercise TrainingNormal Glucose Tolerance
T2DMAerobic Exercise TrainingType 2 Diabetes Mellitus
Primary Outcome Measures
NameTimeMethod
Endothelial progenitor cell number6-month
Skeletal muscle capillarization6-month
Secondary Outcome Measures
NameTimeMethod
Cardiorespiratory Fitness6-month

Trial Locations

Locations (1)

Baltimore VA Medical Center

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath